| Serial Number | 98043024 |
| Word Mark | CANTEX |
| Filing Date | Wednesday, June 14, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, October 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceuticals, namely, Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses; Pharmaceutical preparations for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceutical preparations for inhibiting Receptor for Advanced Glycation End products (RAGE) interactions, for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Pharmaceutical preparations for use in personalized medicine and targeted therapy in the field of Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases |
| Goods and Services | Licensing of pharmaceuticals and drug discovery technologies |
| Goods and Services | Providing medical and scientific research information about the diagnosis and treatment of diseases, namely, infectious diseases, viral diseases, and autoimmune diseases; Providing information in the fields of health, wellness, and pharmaceuticals via a website; all of the foregoing related to Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses |
| Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical research and development; Development of new drugs for the prevention and treatment of cancer and other serious illnesses; Design and testing of new drugs and therapies; Medical and scientific research in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Medical and scientific research consulting in the field of oncology, neurology, pulmonary, renal, cardiac, autoimmune, inflammatory, and infectious diseases; Biological testing and research in the field of pharmaceuticals; all of the foregoing related to Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cantex Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Weston, FL 33326 |
| Event Date | Event Description |
| Saturday, June 17, 2023 | NEW APPLICATION ENTERED |
| Tuesday, July 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 4, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, March 12, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 12, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 29, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, May 29, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Thursday, September 12, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 12, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 12, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 17, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, October 17, 2024 | SUSPENSION LETTER WRITTEN |
| Thursday, October 17, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, October 23, 2024 | WITHDRAWAL OF ATTORNEY GRANTED |
| Wednesday, October 23, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Monday, October 28, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 28, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 28, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, October 28, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 28, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |